124 related articles for article (PubMed ID: 28629782)
1. TNF phase III signalling in tolerant cells is tightly controlled by A20 and CYLD.
Bikker R; Christmann M; Preuß K; Welz B; Friesenhagen J; Dittrich-Breiholz O; Huber R; Brand K
Cell Signal; 2017 Sep; 37():123-135. PubMed ID: 28629782
[TBL] [Abstract][Full Text] [Related]
2. Identification of two forms of TNF tolerance in human monocytes: differential inhibition of NF-κB/AP-1- and PP1-associated signaling.
Günther J; Vogt N; Hampel K; Bikker R; Page S; Müller B; Kandemir J; Kracht M; Dittrich-Breiholz O; Huber R; Brand K
J Immunol; 2014 Apr; 192(7):3143-55. PubMed ID: 24574500
[TBL] [Abstract][Full Text] [Related]
3. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
Li P; Wang Y; Turner JH
Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
[TBL] [Abstract][Full Text] [Related]
5. Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients.
Zamani F; Khalighfard S; Kalhori MR; Poorkhani A; Amiriani T; Hosseinzadeh P; Esmati E; Alemrajabi M; Nikoofar A; Safarnezhad Tameshkel F; Alizadeh AM
Med Oncol; 2023 Sep; 40(10):302. PubMed ID: 37725175
[TBL] [Abstract][Full Text] [Related]
6. Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.
Wu GR; Mu TC; Gao ZX; Wang J; Sy MS; Li CY
J Biol Chem; 2017 Nov; 292(46):18747-18759. PubMed ID: 28900035
[TBL] [Abstract][Full Text] [Related]
7. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
Das T; Chen Z; Hendriks RW; Kool M
Front Immunol; 2018; 9():104. PubMed ID: 29515565
[TBL] [Abstract][Full Text] [Related]
8. TNFα induces tolerant production of CXC chemokines in colorectal cancer HCT116 cells via A20 inhibition of ERK signaling.
Zhou X; An D; Liu X; Jiang M; Yuan C; Hu J
Int Immunopharmacol; 2018 Jan; 54():296-302. PubMed ID: 29175508
[TBL] [Abstract][Full Text] [Related]
9. A20 protects cells from TNF-induced apoptosis through linear ubiquitin-dependent and -independent mechanisms.
Priem D; Devos M; Druwé S; Martens A; Slowicka K; Ting AT; Pasparakis M; Declercq W; Vandenabeele P; van Loo G; Bertrand MJM
Cell Death Dis; 2019 Sep; 10(10):692. PubMed ID: 31534131
[TBL] [Abstract][Full Text] [Related]
10. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
[TBL] [Abstract][Full Text] [Related]
11. Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation.
Bannon A; Zhang SD; Schock BC; Ennis M
Med Princ Pract; 2015; 24(4):301-10. PubMed ID: 25925366
[TBL] [Abstract][Full Text] [Related]
12. LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.
Draber P; Kupka S; Reichert M; Draberova H; Lafont E; de Miguel D; Spilgies L; Surinova S; Taraborrelli L; Hartwig T; Rieser E; Martino L; Rittinger K; Walczak H
Cell Rep; 2015 Dec; 13(10):2258-72. PubMed ID: 26670046
[TBL] [Abstract][Full Text] [Related]
13. [Immune regulation role of A20 and its clinical significance].
Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):851-6. PubMed ID: 21867600
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection.
Liuwantara D; Elliot M; Smith MW; Yam AO; Walters SN; Marino E; McShea A; Grey ST
Diabetes; 2006 Sep; 55(9):2491-501. PubMed ID: 16936197
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
Boone DL; Turer EE; Lee EG; Ahmad RC; Wheeler MT; Tsui C; Hurley P; Chien M; Chai S; Hitotsumatsu O; McNally E; Pickart C; Ma A
Nat Immunol; 2004 Oct; 5(10):1052-60. PubMed ID: 15334086
[TBL] [Abstract][Full Text] [Related]
16. A20 Orchestrates Inflammatory Response in the Oral Mucosa through Restraining NF-κB Activity.
Li Y; Mooney EC; Holden SE; Xia XJ; Cohen DJ; Walsh SW; Ma A; Sahingur SE
J Immunol; 2019 Apr; 202(7):2044-2056. PubMed ID: 30760622
[TBL] [Abstract][Full Text] [Related]
17. A20 zinc finger protein inhibits TNF and IL-1 signaling.
Jäättelä M; Mouritzen H; Elling F; Bastholm L
J Immunol; 1996 Feb; 156(3):1166-73. PubMed ID: 8557994
[TBL] [Abstract][Full Text] [Related]
18. Multifaceted role of the ubiquitin ligase Itch in immune regulation.
Venuprasad K; Zeng M; Baughan SL; Massoumi R
Immunol Cell Biol; 2015; 93(5):452-60. PubMed ID: 25582340
[TBL] [Abstract][Full Text] [Related]
19. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction controls heterogeneous NF-κB dynamics and target gene expression through cytokine-specific refractory states.
Adamson A; Boddington C; Downton P; Rowe W; Bagnall J; Lam C; Maya-Mendoza A; Schmidt L; Harper CV; Spiller DG; Rand DA; Jackson DA; White MR; Paszek P
Nat Commun; 2016 Jul; 7():12057. PubMed ID: 27381163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
